MGMaria V. Gultikova

Maria V. Gultikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria V. Gultikova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis of 4-(N-Benzoylaminoacetyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazaisowurtzitane

    by M. V. Balakhnina, Y. A. Balakhnin, D. I. Koleno, D. A. Kulagina, S. V. Sysolyatin, М. В. Балахнина, Ю. А. Балахнин, Д. И. Колено, Д. А. Кулагина, С. В. Сысолятин

    Synthesis of 4-(N-Benzoylaminoacetyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazaisowurtzitane | Balakhnina | Proceedings of Universities. Applied Chemistry and Biotechnology Синтез 4-(N-бензоиламиноацетил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазаизовюрцитана | Балахнина | Известия вузов. Прикладная химия и биотехнология

  • Исследование 4,10-диморфолинацетил-2,6,8,12-тетраацетил- 2,4,6,8,10,12-гексаазаизовюрцитана в поведенческих тестах на мышах линии CDI

    by Юрий Алексеевич Балахнин, Дарья Александровна Кулагина, Сергей Викторович Сысолятин, Светлана Владимировна Строкова, Мария Владимировна Гультикова, Татьяна Николаевна Поветьева, Николай Иннокентьевич Суслов, Юлия Владимировна Нестерова, Ольга Геннадьевна Афанасьева, Павел Валерьевич Кульпин, et al.

    Разработка новых анксиолитических препаратов имеет важное значение, поскольку в настоящее время в развитых странах растет число заболеваний, связанных с тревожными расстройствами, а препараты для лечения таких заболеваний вызывают огромное число побочных эффектов, особенно при систематическом употреблении, что привлекает большое внимание к их безопасности. 4,10-Диморфолинацетил-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазаизовюрцитан перспективен в качестве анксиолитического средства с низкой токсичностью. Высокая вероятность проявления 4,10-диморфолинацетил-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазаизовюрцитаном анксиолитической активности была рассчитана с помощью интернет-платформы Pass-online. В данной статье рассматривается его способ получения с выходом 83 % и чистотой 99,6 %, а также биологические исследования in vivo, которые подтверждают точность прогноза in silico.

  • SYNTHESIS AND STUDY OF NEW 5-AMINO-1,2,3-TRIAZOLES AS POTENTIAL ANTITUMOR AGENTS

    by Svetlana V. Strokova, Maxim A. Lenskiy, Daria N. Vilisova, Sergey V. Sysolyatin, Maria V. Gultikova

    Despite the wide range of drugs, the problems of insufficient efficiency and side effects remain relevant, which stimulates active searches for new biologically active compounds with improved therapeutic properties. In this regard, derivatives of 1,2,3-triazoles-heterocyclic structures are of great interest, possessing great potential for the development of new effective pharmaceuticals, due to their wide range of biological activity, including antimicrobial, antitumor, antiviral. This necessitates the study of their properties, the search for ways to synthesize new molecules and the methods for obtaining already known compounds optimization. In this work, the synthesis of new 5-amino-1,2,3-triazoles derivatives by the cyanoacetic ester with 2-(azidomethyl)-1H-benzoimidazole and 2-azidoacetamide reaction is presented. Optimization of cycloaddition conditions in the systems: DMSO/potassium carbonate, DMSO/sodium methylate and methanol/sodium methylate was carried out. The key role of the solvent and base on the reaction efficiency is shown, which ensures the target product maximum yield. Products highest yield was achieved in the methanol/sodium methylate system. Hydrolysis of synthesized 1,2,3-triazoles esters leads to carboxylic and dicarboxylic acids, which have not been previously described in the literature. All new compounds obtained in the work were confirmed with IR and 1H, 13C NMR spectroscopy. All the new compounds obtained in the work have a high predictive exhibiting antitumor activity probability, according to the computer analysis results in the PASSonline program. The results on the 5-amino-1,2,3-triazole-4-carboxylates and their carboxylic acids synthesis studies make it possible to expand the potential substances range for the oncological diseases treatment and contribute to the 5-amino-1,2,3-triazoles chemistry development. For citation: Strokova S.V., Lenskiy M.A., Vilisova D.N., Sysolyatin S.V., Gultikova M.V. Synthesis and study of new 5-amino-1,2,3-triazoles as potential antitumor agents. ChemChemTech [Izv. Vyssh. Uchebn. Zaved. Khim. Khim. Tekhnol.]. 2026. V. 69. N 3. P. 96-104. DOI: 10.6060/ivkkt.20266903.7257.